Τα γενόσημα φάρμακα στην ελληνική αγορά υπό το πρίσμα των γιατρών - φαρμακοποιών και ασθενών
Generic medicines on the Greek market from the doctors - pharmacists and patients point of view
View/
Keywords
Εθνικός Οργανισμός Φαρμάκων (ΕΟΦ) ; Φαρμακευτικές δαπάνες ; Γενόσημα φάρμακα ; Φαρμακευτικός κλάδος ; Φαρμακευτική βιομηχανίαAbstract
As a result of the economic pressure concerned with reducing pharmaceutical expenditure, the widespread use of generics is both necessary and indispensable around the world in order to accomplish this much needed reduction in expenditure. Health care has been recognized at the High Level Pharmaceutical Forum, and these said generic medicines provide an opportunity to obtain treatments at a lower cost for insurers.
The purpose of this paper is to highlight the magnitude of the use of generic drugs on the Greek market and in other European countries, found in fiscal policy plans. The methodology used to obtain information on the use of generic drugs included the narrative literature review, which was based on books, articles and sites from the internet. The countries which were selected to be examined were Greece, Germany, Denmark and Poland, where there is a rapid growth in the generics market as opposed to countries such as France, Portugal and Austria which show a negligible growth in the generics market. Talks are being held in these countries, because we want to show the policies and the methods for the promotion of generic drugs, but also the reasons for the failure of these actions.
Postgraduate Studies Programme
Οικονομικά και Διοίκηση της ΥγείαςDepartment
Σχολή Οικονομικών, Επιχειρηματικών και Διεθνών Σπουδών. Τμήμα Οικονομικής ΕπιστήμηςNumber of pages
82Language
GreekCollections
Except where otherwise noted, this item's license is described as
Attribution-NonCommercial-NoDerivatives 4.0 Διεθνές
Attribution-NonCommercial-NoDerivatives 4.0 Διεθνές